Published in AIDS Weekly, May 12th, 1997
Hiroshi Nakajima, director general of the United Nations agency, said the combination of three drugs including a protease inhibitor showed "impressive results" in treating AIDS patients.
But he pointed out that the longest clinical trials with the new triple therapies have lasted only two years and that there remain questions about resistance to them.
Nakajima urged policymakers not to "abandon their commitment to essential long-term activities such as prevention programs and the search for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.